🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, open-label, randomized controlled trial that e...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-09-25
Trial ID
NCT07165418
Treatments Being Tested
The purpose of this study is to learn what effects, good and/or bad, Everol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-12-05
Trial ID
NCT00805129
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
This study is designed to assess the safety and efficacy of RAD001 monother...
Status
Completed
Location
Highlands Oncology Group DeptofHighlandsOncologyGrp(2)
Start Date
2009-07
Trial ID
NCT00879333
Treatments Being Tested
The purpose of this study is to compare treatment with RAD001 plus best sup...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2010-04
Trial ID
NCT01035229
Treatments Being Tested
This international, multi-center, open-label, single-arm study evaluated th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-29
Trial ID
NCT03176238
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
The purpose of this study was to compare the safety and efficacy of three i...
Status
Completed
Location
Novartis
Start Date
2005-10
Trial ID
NCT00251004
Treatments Being Tested
This study was to evaluate the antitumor activity and safety of RAD001 in p...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01365468
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048